查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
週邊血管器材市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1348912

週邊血管器材市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、最終用戶、地區和競爭細分

Peripheral Vascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 173 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球週邊血管器械市場在預測期內將出現令人印象深刻的成長。這可以歸因於老年人口的成長以及全球週邊血管疾病盛行率的增加。此外，週邊血管手術的有利報銷方案預計將在預測期內創造利潤豐厚的成長。同樣，產品批准數量的增加以及糖尿病盛行率的增加是多年來推動市場成長的主要因素。此外，預計菸草消費率的上升將推動多年來市場的成長。 2022年3月，西門子醫療在美國推出了新一代ACUSON AcuNav Volume 4D ICE導管。據該公司稱，AcuNav Volume ICE 導管可以治療以前無法接受結構性心臟手術的患者，從而改變了護理服務。

人口老化

人口老化是推動全球週邊血管器械市場成長的關鍵因素之一。隨著年齡的成長，他們更有可能患上周圍血管疾病，這會影響心臟和大腦以外的血管。這些疾病包括週邊動脈疾病 (PAD)、深部靜脈血栓 (DVT) 和靜脈功能不全等。此外，老年人往往更容易出現週邊血管疾病的併發症，例如截肢、中風和心臟病。這給醫療保健系統造成了巨大的負擔，增加了對用於診斷和治療的周邊血管設備的需求。此外，人口老化更容易出現其他合併症，如糖尿病和高血壓，這些都是周邊血管疾病的危險因子。由於這些慢性疾病的盛行率也隨著年齡的成長而增加，因此對治療這些疾病的周邊血管裝置的需求也隨之增加。

市場概況
預測期 2024-2028
2022 年市場規模 110612萬美元
2028 年市場規模 161726萬美元
年複合成長率 6.49%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

慢性病盛行率上升

糖尿病和高血壓等慢性病是全球週邊血管器械市場成長的主要驅動力。這些情況可能會導致周邊血管疾病的發生，進而影響心臟和大腦以外的血管。週邊血管疾病包括週邊動脈疾病（PAD）、深部靜脈血栓（DVT）及靜脈功能不全等。隨著糖尿病、高血壓等慢性病在全球的盛行率持續上升，週邊血管疾病的發生率也不斷上升。根據國際糖尿病聯盟的數據，到2045 年，全球糖尿病盛行率預計將從2013 年的8.3% 上升至10.9%。糖尿病是周邊血管疾病的重要危險因子，尤其是周邊動脈疾病(PAD)，估計影響20% 的人口患有糖尿病。高血壓是周邊血管疾病的另一個主要危險因子。據世界衛生組織稱，高血壓影響全球約 11.3 億人，估計每年導致 940 萬人死亡。高血壓會損害血管並減少血流量，從而導致周邊動脈疾病 (PAD) 和其他週邊血管疾病的發生。糖尿病和高血壓等慢性病的盛行率不斷上升，推動了對用於診斷、治療和管理週邊血管疾病的周邊血管器械的需求。這些裝置包括支架、導管、球囊以及用於微創手術（例如血管成形術和斑塊切除術）的其他裝置。

技術進步

技術進步對推動全球週邊血管器械市場的成長發揮了重要作用。這些進步導致了新的和改進的設備的開發，以及用於診斷、治療和管理周圍血管疾病的新程序和技術。近年來最重要的進展之一是針對週邊血管疾病的微創手術的發展，例如血管成形術和斑塊旋切術。這些手術使用小切口和專用工具來治療阻塞或狹窄的血管，減少開放性手術的需要並最大限度地縮短恢復時間。成像技術的進步也在市場的成長中發揮了關鍵作用。磁振造影血管攝影（MRA）和電腦斷層血管攝影（CTA）等影像技術的改進使得診斷和評估週邊血管疾病變得更加容易，從而可以製定更準確的治療計劃。此外，生物可吸收支架、藥物洗脫球囊等器械材料也取得了重大進展，提高了周邊血管器械的安全性和有效性。推動市場成長的另一個技術進步領域是遠距患者監護系統的發展。這些系統允許醫療保健提供者遠端監測患有周圍血管疾病的患者，減少頻繁去醫院的需要並改善患者的治療結果。

增加醫療保健支出

醫療支出是影響全球週邊血管器材市場成長的重要因素。隨著醫療保健支出的增加，對用於診斷、治療和管理週邊血管疾病的醫療設備（包括週邊血管設備）的需求通常也會相應增加。此外，糖尿病和高血壓等慢性病的盛行率不斷上升，這些疾病是周邊血管疾病的重要危險因素，也推動了醫療支出。這些情況需要持續的管理和治療，包括使用周邊血管裝置，以預防肢體截肢、中風和心臟病等併發症。此外，隨著醫療保健系統努力降低成本和提高效率，人們越來越關注週邊血管疾病的預防保健和早期診斷。這導致對篩檢和診斷工具的投資增加，例如影像技術和生物標記測試，這有助於及早發現周圍血管疾病，並防止以後需要更昂貴的干涉措施。

優惠報銷政策

報銷政策是影響全球週邊血管器械市場成長的重要因素。報銷政策決定了醫療保健提供者和患者可以從保險公司和政府計劃獲得的金額，以支付醫療程序和設備（包括週邊血管設備）的費用。在許多國家，政府和私人保險計劃為患有某些疾病（例如周邊動脈疾病或深部靜脈栓塞）的患者支付週邊血管裝置的費用。報銷政策對新型和創新週邊血管設備的採用具有重大影響，因為提供者和患者更有可能使用保險承保的設備。此外，報銷政策的變化可能會對市場的成長產生重大影響。例如，政府或保險公司決定減少週邊血管裝置的報銷可能會導致對這些裝置的需求下降。此外，報銷政策的複雜性也可能成為市場成長的障礙。獲得周邊血管裝置報銷的過程可能既耗時又複雜，這可能會阻止醫療保健提供者使用這些裝置。

最近的發展

  • Stellarex PTX DCB - 2022年，飛利浦推出了Stellarex PTX藥物塗層球囊，旨在治療週邊動脈疾病患者。該裝置使用藥物塗層球囊將抗增生藥物輸送到動脈阻塞部位，降低再狹窄的風險。
  • Tigereye Guidewire - 2022 年，波士頓科學公司推出了 Tigereye Guidewire，這是一種用於在血管內手術期間進入和導航外周脈管系統的設備。導絲具有親水塗層，增強了其在曲折解剖結構中導航的能力。
  • Luminor35 微導管 - 2022 年，AngioDynamics 推出了 Luminor 35 微導管，旨在促進進入周邊脈管系統中的小血管。該設備具有軟性軸和親水塗層，增強了其導航性和易用性。
  • iCAST Flex 週邊支架 - 2022 年，Atrium Medical 推出了 iCAST Flex 週邊支架，旨在治療小腿週邊動脈疾病患者。該支架採用鎳鈦諾線框，使其能夠部署在複雜的解剖結構中，同時保持徑向強度。
  • VascuFlex Multi-LOC - 2020 年，B. Braun Melsungen AG 推出了 VascuFlex Multi-LOC，這是一種自膨脹式鎳鈦合金支架系統，設計用於治療股膕動脈外周動脈疾病。
  • HawkOne 定向斑塊切除系統 - 2019 年，美敦力推出了 HawkOne 定向斑塊切除系統，該設備旨在清除因週邊動脈疾病導致的腿部血管阻塞中的斑塊。
  • EnVivo 可扭轉微導管 - 2018 年，波士頓科學公司推出了 EnVivo 可扭轉微導管，這是一種用於週邊血管手術的設備，可將診斷或治療藥物輸送到脈管系統內的特定位置。
  • EluNIR 藥物洗脫支架系統 - 2018 年，美敦力推出了 EluNIR 藥物洗脫支架系統，這是一種設計用於治療股膕動脈周圍動脈疾病的設備。
  • IN.PACT Admiral 藥物塗層球囊 - 2018 年，美敦力還推出了 IN.PACT Admiral 藥物塗層球囊，該裝置用於通過打開狹窄或阻塞的血管並釋放藥物來預防腿部外周動脈疾病。疤痕組織的形成。

市場區隔

全球週邊血管器械市場可以按類型、最終用戶、地區和競爭格局進行細分。依類型，市場可分為週邊支架、PTA球囊、導管、血管內動脈瘤修補覆膜支架、斑塊修飾裝置、週邊配件、下腔靜脈過濾器、血流動力學改變裝置。根據最終用戶，市場可分為醫院、診所、門診手術中心。

市場參與者

Abbott Laboratories.、AngioScore Inc.、Edward Lifesciences Corporation.、Medtronic Inc.、St. Jude Medical.、Teleflex Medical.、Volcano Corporation.、Boston Scientific Corporation.、Teleflex Medical.、Cook Group Inc.、Cordis Corporation、Covidien、 WL Gore and Associates Ltd 是全球週邊血管器材市場的一些領先參與者。

報告範圍：

在本報告中，除了以下詳細介紹的產業趨勢外，全球週邊血管器械市場還分為以下幾類：

週邊血管器械市場，依類型：

  • 外周支架
  • PTA 氣球
  • 導管
  • 血管內動脈瘤修補覆膜支架
  • 斑塊修飾裝置
  • 週邊配件
  • 下腔靜脈過濾器
  • 血流動力學流量改變裝置

週邊血管器械市場，依最終用戶分類：

  • 醫院
  • 診所
  • 門診手術中心

週邊血管器械市場（按地區）：

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

競爭格局

公司概況：全球週邊血管器械市場主要公司的詳細分析。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（週邊支架、PTA 球囊、導管、血管內動脈瘤修補覆膜支架、斑塊修飾裝置、週邊配件、下腔靜脈過濾器、血流動力學改變裝置）
    • 按最終使用者（醫院和診所、門診手術中心、其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按類型
    • 由最終用戶
    • 按地區

第 6 章：北美週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲週邊血管器械市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非週邊血管裝置
    • 沙烏地阿拉伯週邊血管裝置
    • 阿拉伯聯合大公國週邊血管裝置

第 11 章：市場動態

  • 動力
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球週邊血管器械市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Abbott Laboratories, Inc.
    • Angioscore Inc.
    • Edward Lifesciences Corporation.
    • Medtronic Plc.
    • Teleflex Medical.
    • Volcano Corporation.
    • Boston Scientific Corporation.
    • Teleflex Medical.
    • Cook Group Inc.
    • Cordis Corporation

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 15454

Global Peripheral Vascular Devices market is anticipated to witness impressive growth during the forecast period. This can be ascribed to growing geriatric population along with a subsequent increase in the prevalence of peripheral vascular diseases across the globe. Also, the favorable reimbursement scenario for peripheral vascular procedures is expected to create lucrative growth during the forecast period. Similarly, increasing number of product approvals along with the growing prevalence of diabetes are major factors driving the growth of the market over the years. Additionally, rising the rate of tobacco consumption is anticipated to boost the growth of the market over the years. In March 2022, Siemens Healthineers launched next-generation ACUSON AcuNav Volume 4D ICE Catheter in the United States. As per the company, AcuNav Volume ICE catheter transforms care delivery by enabling the treatment of patients who were previously not able to undergo structural heart procedures.

Aging population

The aging population is one of the key factors driving the growth of the global peripheral vascular devices market. As people age, they are more likely to develop peripheral vascular diseases, which can affect the blood vessels outside of the heart and brain. These conditions include peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency, among others. Furthermore, the elderly population is often more susceptible to the complications of peripheral vascular diseases, such as limb amputation, stroke, and heart attack. This creates a significant burden on healthcare systems, increasing the demand for peripheral vascular devices for diagnosis and treatment. In addition, the aging population is more likely to have other comorbidities, such as diabetes and hypertension, which are risk factors for peripheral vascular diseases. As the prevalence of these chronic diseases also increases with age, the demand for peripheral vascular devices to manage these conditions also increases.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1106.12 Million
Market Size 2028USD 1617.26 Million
CAGR (2023-2028)6.49%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Rising prevalence of chronic diseases

Chronic diseases such as diabetes and hypertension are major drivers of the growth of the global peripheral vascular devices market. These conditions can contribute to the development of peripheral vascular diseases, which affect the blood vessels outside of the heart and brain. Peripheral vascular diseases include peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency, among others. As the prevalence of chronic diseases such as diabetes and hypertension continue to increase worldwide, so too does the incidence of peripheral vascular diseases. According to the International Diabetes Federation, the global prevalence of diabetes is expected to reach 10.9% by 2045, up from 8.3% in 2013. Diabetes is a significant risk factor for peripheral vascular diseases, particularly PAD, which affects an estimated 20% of people with diabetes. Hypertension, or high blood pressure, is another major risk factor for peripheral vascular diseases. According to the World Health Organization, hypertension affects around 1.13 billion people worldwide, and is responsible for an estimated 9.4 million deaths each year. Hypertension can contribute to the development of PAD and other peripheral vascular diseases by damaging blood vessels and reducing blood flow. The growing prevalence of chronic diseases such as diabetes and hypertension are driving demand for peripheral vascular devices for diagnosis, treatment, and management of peripheral vascular diseases. These devices include stents, catheters, balloons, and other devices used in minimally invasive procedures such as angioplasty and atherectomy.

Technological advances

Technological advances have played a significant role in driving the growth of the global peripheral vascular devices market. These advances have led to the development of new and improved devices, as well as new procedures and techniques for diagnosis, treatment, and management of peripheral vascular diseases. One of the most significant advances in recent years has been the development of minimally invasive procedures for peripheral vascular diseases, such as angioplasty and atherectomy. These procedures use small incisions and specialized tools to treat blocked or narrowed blood vessels, reducing the need for open surgery and minimizing recovery time. Advances in imaging technology have also played a key role in the growth of the market. Improved imaging techniques such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA) have made it easier to diagnose and assess peripheral vascular diseases, allowing for more accurate treatment planning. In addition, there have been significant advances in device materials, such as bioresorbable stents and drug-eluting balloons, which have improved the safety and efficacy of peripheral vascular devices. Another area of technological advancement that is driving growth in the market is the development of remote patient monitoring systems. These systems allow healthcare providers to monitor patients with peripheral vascular diseases remotely, reducing the need for frequent hospital visits and improving patient outcomes.

Increasing healthcare expenditure

Healthcare expenditure is a significant factor that influences the growth of the global peripheral vascular devices market. As healthcare expenditure increases, there is typically a corresponding increase in demand for medical devices, including peripheral vascular devices, to diagnose, treat, and manage peripheral vascular diseases. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are significant risk factors for peripheral vascular diseases, is also driving healthcare expenditure. These conditions require ongoing management and treatment, including the use of peripheral vascular devices, to prevent complications such as limb amputation, stroke, and heart attack. Furthermore, as healthcare systems strive to reduce costs and improve efficiency, there is a growing focus on preventive care and early diagnosis of peripheral vascular diseases. This has led to increased investment in screening and diagnostic tools, such as imaging technology and biomarker tests, which can help identify peripheral vascular diseases early and prevent the need for more costly interventions later on.

Favorable reimbursement policies

Reimbursement policies are a significant factor that influences the growth of the global peripheral vascular devices market. Reimbursement policies determine the amount of money that healthcare providers and patients can receive from insurance companies and government programs to cover the cost of medical procedures and devices, including peripheral vascular devices. In many countries, government and private insurance programs cover the cost of peripheral vascular devices for patients with certain medical conditions, such as peripheral artery disease or deep vein thrombosis. Reimbursement policies have a significant impact on the adoption of new and innovative peripheral vascular devices, as providers and patients are more likely to use devices that are covered by insurance. Furthermore, changes in reimbursement policies can have a significant impact on the growth of the market. For example, a decision by a government or insurance provider to reduce reimbursement for peripheral vascular devices could lead to a decline in demand for those devices. In addition, the complexity of reimbursement policies can also be a barrier to market growth. The process of obtaining reimbursement for peripheral vascular devices can be time-consuming and complicated, which can deter healthcare providers from using these devices.

Recent Developments

  • Stellarex PTX DCB - In 2022, Philips launched the Stellarex PTX drug-coated balloon, which is designed to treat patients with peripheral artery disease. The device uses a drug-coated balloon to deliver an anti-proliferative drug to the site of the arterial blockage, reducing the risk of restenosis.
  • Tigereye Guidewire - In 2022, Boston Scientific launched the Tigereye Guidewire, a device used to access and navigate through the peripheral vasculature during endovascular procedures. The guidewire features a hydrophilic coating that enhances its ability to navigate through tortuous anatomy.
  • Luminor35 Microcatheter - In 2022, AngioDynamics launched the Luminor 35 microcatheter, which is designed to facilitate access to small vessels in the peripheral vasculature. The device features a flexible shaft and a hydrophilic coating that enhances its navigability and ease of use.
  • iCAST Flex Peripheral Stent - In 2022, Atrium Medical launched the iCAST Flex peripheral stent, which is designed to treat patients with peripheral artery disease in the lower leg. The stent features a nitinol wire frame that allows it to be deployed in complex anatomies, while maintaining radial strength.
  • VascuFlex Multi-LOC - In 2020, B. Braun Melsungen AG launched VascuFlex Multi-LOC, a self-expanding nitinol stent system designed for the treatment of peripheral artery disease in the femoropopliteal arteries.
  • HawkOne Directional Atherectomy System - In 2019, Medtronic launched the HawkOne Directional Atherectomy System, a device designed to remove plaque from blocked blood vessels in the legs due to peripheral artery disease.
  • EnVivo Torqueable Microcatheter - In 2018, Boston Scientific launched the EnVivo Torqueable Microcatheter, a device used in peripheral vascular procedures to deliver diagnostic or therapeutic agents to specific locations within the vasculature.
  • EluNIR Drug-Eluting Stent System - In 2018, Medtronic launched the EluNIR Drug-Eluting Stent System, a device designed for the treatment of peripheral artery disease in the femoropopliteal arteries.
  • IN.PACT Admiral Drug-Coated Balloon - In 2018, Medtronic also launched the IN.PACT Admiral Drug-Coated Balloon, a device used to treat peripheral artery disease in the legs by opening narrowed or blocked blood vessels and releasing a drug to prevent the formation of scar tissue.

Market Segmentation

Global Peripheral Vascular Devices market can be segmented by type, end user, by region and competitive landscape. Based on the type, the market can be segmented into Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices. Based on end user the market can be differentiated into Hospitals, Clinics, Ambulatory Surgical Centers.

Market Players

Abbott Laboratories., AngioScore Inc., Edward Lifesciences Corporation., Medtronic Inc., St. Jude Medical., Teleflex Medical., Volcano Corporation., Boston Scientific Corporation., Teleflex Medical., Cook Group Inc., Cordis Corporation, Covidien, W.L. Gore and Associates Ltd are some of the leading players operating in the Global Peripheral Vascular Devices Market.

Report Scope:

In this report, Global Peripheral Vascular Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peripheral Vascular Devices Market, By Type:

  • Peripheral Stents
  • PTA Balloons
  • Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Plaque Modification Devices
  • Peripheral Accessories
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices

Peripheral Vascular Devices Market, By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Peripheral Vascular Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peripheral Vascular Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peripheral Vascular Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Type
    • 5.3.2 By End Users
    • 5.3.3 By Region

6. North America Peripheral Vascular Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peripheral Vascular Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Peripheral Vascular Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Peripheral Vascular Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Peripheral Vascular Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Peripheral Vascular Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Peripheral Vascular Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Peripheral Vascular Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Peripheral Vascular Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Peripheral Vascular Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Peripheral Vascular Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Peripheral Vascular Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Peripheral Vascular Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Peripheral Vascular Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Peripheral Vascular Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Peripheral Vascular Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Peripheral Vascular Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Peripheral Vascular Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Peripheral Vascular Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Peripheral Vascular Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Peripheral Vascular Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Peripheral Vascular Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Peripheral Vascular Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Peripheral Vascular Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Peripheral Vascular Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Abbott Laboratories, Inc.
    • 15.6.2. Angioscore Inc.
    • 15.6.3. Edward Lifesciences Corporation.
    • 15.6.4. Medtronic Plc.
    • 15.6.5. Teleflex Medical.
    • 15.6.6. Volcano Corporation.
    • 15.6.7. Boston Scientific Corporation.
    • 15.6.8. Teleflex Medical.
    • 15.6.9. Cook Group Inc.
    • 15.6.10. Cordis Corporation

16. Strategic Recommendations

17. About Us & Disclaimer